MRI was performed using 3‐Tesla MRI (Siemens Magnetom Triop and Verio). In rare instances, 1.5‐Tesla MRI (GE
Optima MR450W) was employed when use of 3‐T coil was contraindicated. An endorectal coil was used for cases prior to 2019, after which it was routinely omitted for most patients. Postimage processing used
DynaCAD software (Philips Healthcare, Best, Netherlands). MRI images were graded by experienced but nondedicated faculty using PI‐RADS version 2.0 or 2.1.
11 (
link)
All MRI‐TRUS fusion biopsies were performed transrectally by experienced urologists using the UroNav system (Invivo, Philips Healthcare). Transperineal biopsy was introduced after the study period. Standard template biopsies included two biopsy cores taken from each sextet region. Targeted biopsies were obtained at the discretion of the urologist; PI‐RADS 3‐5 lesions were routinely biopsied with two cores, while PI‐RADS 2 lesions were rarely sampled.
Patel H.D., Halgrimson W.R., Sweigert S.E., Shea S.M., Turk T.M., Quek M.L., Gorbonos A., Flanigan R.C., Goldberg A, & Gupta G.N. (2023). Variability in prostate cancer detection among radiologists and urologists using MRI fusion biopsy. BJUI Compass, 5(2), 304-312.